The Discounted Cash Flow (DCF) valuation of Harmony Biosciences Holdings Inc (HRMY) is 56.64 USD. With the latest stock price at 34.71 USD, the upside of Harmony Biosciences Holdings Inc based on DCF is 63.2%.
Based on the latest price of 34.71 USD and our DCF valuation, Harmony Biosciences Holdings Inc (HRMY) is a buy. buying HRMY stocks now will result in a potential gain of 63.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.7% | 8.0% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 38.91 - 124.26 | 56.64 |
| Upside | 12.1% - 258.0% | 63.2% |